title: Targeting cyclooxygenase-2 for cancer prevention and treatment.
authors.affiliation: RND Pharmaceuticals, Inc., 853 N. Quentin Road, Suite 195, Palatine, IL 60067, USA. SGATELY@RNDPHARM.COM
authors.forename: Stephen T
authors.initials: ST
authors.lastname: Gately
mesh_terms: D000818:Animals; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000517:prevention & control
chemical_list: D016861:Cyclooxygenase Inhibitors